Drugs / XTL-2125
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00255359 | Feb 2006 → Nov 2007 | chronic hepatitis C virus infection | Hadassah Medical Organization | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | XTL-2125 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00255359 ↗ |
| Route | Oral | “single oral dose of either XTL 2125 or placebo” NCT00255359 ↗ |